Search

Your search keyword '"C. glabrata"' showing total 140 results

Search Constraints

Start Over You searched for: Descriptor "C. glabrata" Remove constraint Descriptor: "C. glabrata" Search Limiters Full Text Remove constraint Search Limiters: Full Text
140 results on '"C. glabrata"'

Search Results

1. Lack of Candida africana in Ugandan pregnant women: results from a pilot study using MALDI-ToF.

2. Lack of Candida africana in Ugandan pregnant women: results from a pilot study using MALDI-ToF

Catalog

Books, media, physical & digital resources

3. Decoding the role of oxidative stress resistance and alternative carbon substrate assimilation in the mature biofilm growth mode of Candida glabrata

4. Decoding the role of oxidative stress resistance and alternative carbon substrate assimilation in the mature biofilm growth mode of Candida glabrata.

5. Inhibitors of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Decrease the Growth, Ergosterol Synthesis and Generation of petite Mutants in Candida glabrata and Candida albicans.

6. Cinnamaldehyde Loaded Poly(lactide-co-glycolide) (PLGA) Microparticles for Antifungal Delivery Application against Resistant Candida albicans and Candida glabrata.

7. Anti-Candidal Activity of Reboxetine and Sertraline Antidepressants: Effects on Pre-Formed Biofilms.

8. Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy

9. Thymus vulgaris Essential Oil in Beta-Cyclodextrin for Solid-State Pharmaceutical Applications.

10. Commiphora wildii Merxm. Essential Oil: Natural Heptane Source and Co-Product Valorization.

11. Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression

12. Characterization of the Secretome of Pathogenic Candida glabrata and Their Effectiveness against Systemic Candidiasis in BALB/c Mice for Vaccine Development.

13. Extracts from Cabbage Leaves: Preliminary Results towards a "Universal" Highly-Performant Antibacterial and Antifungal Natural Mixture.

14. Cinnamaldehyde Loaded Poly(lactide-co-glycolide) (PLGA) Microparticles for Antifungal Delivery Application against Resistant Candida albicans and Candida glabrata

15. Anti-Candidal Activity of Reboxetine and Sertraline Antidepressants: Effects on Pre-Formed Biofilms

16. Candidemia in pediatric burn patients: Risk factors and outcomes in a retrospective cohort study

17. Thymus vulgaris Essential Oil in Beta-Cyclodextrin for Solid-State Pharmaceutical Applications

18. Commiphora wildii Merxm. Essential Oil: Natural Heptane Source and Co-Product Valorization

19. Clonal evolution of Candida albicans, Candida glabrata and Candida dubliniensis at oral niche level in health and disease.

20. Some issues of the resistance of Candida glabrata to echinocandins

21. Characterization of the Secretome of Pathogenic Candida glabrata and Their Effectiveness against Systemic Candidiasis in BALB/c Mice for Vaccine Development

22. Clonal evolution of Candida albicans, Candida glabrata and Candida dubliniensis at oral niche level in health and disease

23. In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and-Susceptible Candida glabrat.

24. Amphotericin B Polymer Nanoparticles Show Efficacy against Candida Species Biofilms

25. Cinnamaldehyde Loaded Poly(lactide-co-glycolide) (PLGA) Microparticles for Antifungal Delivery Application against Resistant Candida albicans and Candida glabrata

26. Inhibition of recombinant enzyme 3-hydroxy-3-methylglutaryl-CoA reductase from Candida glabrata by α-asarone-based synthetic compounds as antifungal agents.

27. In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and -Susceptible Candida glabrata

28. Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates

29. Effects of Storage Temperature and pH on the Antifungal Effects of Commercial Oral Moisturizers against Candida albicans and Candida glabrata

30. Evolution of reduced co-activator dependence led to target expansion of a starvation response pathway

31. The inhibitory effects of tyrosol on clinical Candida glabrata planktonic and biofilm cells

32. Assessment of in vitro antifungal activity of preparation 'fin Candimis' against Candida strains

33. Determination of antifungal susceptibility patterns among the clinical isolates of Candida species

34. Intractable urinary tract infection in a renal transplant recipient

35. Amphotericin B Polymer Nanoparticles Show Efficacy against

36. A Systematic Study of the Antibacterial Activity of Basidiomycota Crude Extracts

37. Biocatalytic reduction of racemic 2-arenoxycycloalkanones by yeasts P. glucozyma and C. glabrata: one way of achieving chiral 2-arenoxycycloalcohols.

38. Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance.

39. Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates.

40. Some issues of the resistance of Candida glabrata to echinocandins

41. Candidemia in pediatric burn patients: Risk factors and outcomes in a retrospective cohort study

42. Secretion of the acid trehalase encoded by the CgATH1 gene allows trehalose fermentation by Candida glabrata.

43. Development of Polythiourethane/ZnO-Based Anti-Fouling Materials and Evaluation of the Adhesion of Staphylococcus aureus and Candida glabrata Using Single-Cell Force Spectroscopy

44. Global trends in the distribution of Candida species causing candidemia.

45. Effects of Storage Temperature and pH on the Antifungal Effects of Commercial Oral Moisturizers against Candida Albicans and Candida Glabrata

47. Function and regulation of Candida albicans and C. glabrata carboxylic acid transporters and their Role in biofilm formation, antifungal drug resistance and phagocytosis

48. Underlying resistance mechanisms of C. glabrata - Differentiation of polymorphisms and resistance causal mutations in CgPDR1, ERG11, ERG3, FKS1, FKS2, FUR1 and MSH2, of C. glabrata

49. Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy.

50. Determination of Antifungal Susceptibility Patterns Among the Clinical Isolates of Candida Species.